FDA decision on young adulthood, “morning-after” blocked
Indeed, FDA administrator Dr. Margaret Hamburg made plain here her own statement so as to the decision is highly curious. She whispered her agencys drug-safety experts had carefully considered the question of undeveloped girls and so as to she had agreed so as to design Bs age limit ought to occur lifted. near is tolerable and reasonable, well-supported and science-based evidence with the purpose of proposal B One-Step is safe and actual and must occur accepted pro nonprescription employment pro all females of child-bearing possible, Hamburg wrote. But, she added, she had followed her boss order to deny Tevas diligence. We commit the FDA in lieu of making the recommendation .